SGMT vs. NBIS
SGMT (Sagimet Biosciences Inc.) and NBIS (Nebius Group N.V.) are both stocks. SGMT operates in Biotechnology (Healthcare), while NBIS operates in Internet Content & Information (Communication Services). Over the past year, SGMT returned -24.74% vs 362.13% for NBIS. At a 0.17 correlation, their price movements are largely independent.
Performance
SGMT vs. NBIS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SGMT achieves a 9.46% return, which is significantly lower than NBIS's 177.59% return.
SGMT
- 1D
- 0.78%
- 1M
- -14.74%
- YTD
- 9.46%
- 6M
- 4.01%
- 1Y
- -24.74%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NBIS
- 1D
- 4.55%
- 1M
- 12.10%
- YTD
- 177.59%
- 6M
- 164.98%
- 1Y
- 362.13%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SGMT vs. NBIS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
SGMT Sagimet Biosciences Inc. | 9.46% | 31.56% | -16.67% |
NBIS Nebius Group N.V. | 177.59% | 202.18% | 46.25% |
Correlation
The correlation between SGMT and NBIS is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2024 | 0.17 |
Fundamentals
SGMT:
$210.99M
NBIS:
$71.79B
SGMT:
-$1.34
NBIS:
$3.17
SGMT:
2.06
NBIS:
9.91
SGMT:
$0.00
NBIS:
$877.90M
SGMT:
$0.00
NBIS:
$420.60M
SGMT:
-$48.74M
NBIS:
-$52.78M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SGMT vs. NBIS — Risk / Return Rank
SGMT
NBIS
SGMT vs. NBIS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sagimet Biosciences Inc. (SGMT) and Nebius Group N.V. (NBIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SGMT | NBIS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.76 | ||
| Sortino ratioReturn per unit of downside risk | -3.53 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.42 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.45 | 8.03 | -8.47 |
| Martin ratioReturn relative to average drawdown | -0.73 | 18.34 | -19.07 |
Loading charts...
Drawdowns
SGMT vs. NBIS - Drawdown Comparison
The maximum SGMT drawdown since its inception was -89.69%, which is greater than NBIS's maximum drawdown of -58.27%. Use the drawdown chart below to compare losses from any high point for SGMT and NBIS.
Loading charts...
Drawdown Indicators
| SGMT | NBIS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.69% | -58.27% | -31.42% |
Max Drawdown (1Y)Largest decline over 1 year | -55.57% | -45.47% | -10.10% |
Current DrawdownCurrent decline from peak | -64.82% | -12.15% | -52.67% |
Average DrawdownAverage peak-to-trough decline | -65.85% | -18.94% | -46.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.91% | 19.86% | +14.05% |
Volatility
SGMT vs. NBIS - Volatility Comparison
The current volatility for Sagimet Biosciences Inc. (SGMT) is 13.28%, while Nebius Group N.V. (NBIS) has a volatility of 30.23%. This indicates that SGMT experiences smaller price fluctuations and is considered to be less risky than NBIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SGMT | NBIS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.28% | 30.23% | -16.95% |
Volatility (6M)Calculated over the trailing 6-month period | 59.70% | 71.43% | -11.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.42% | 104.41% | -3.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 150.96% | 110.20% | +40.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 150.96% | 110.20% | +40.76% |
Dividends
SGMT vs. NBIS - Dividend Comparison
Neither SGMT nor NBIS has paid dividends to shareholders.
Financials
SGMT vs. NBIS - Financials Comparison
This section allows you to compare key financial metrics between Sagimet Biosciences Inc. and Nebius Group N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SGMT and NBIS have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIS has higher volatility (30.23%) compared to SGMT (13.28%). In terms of maximum drawdown, SGMT dropped -89.69% vs NBIS's -58.27%.
NBIS currently has the higher Sharpe Ratio (3.50 vs -0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SGMT and NBIS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer